W.L. Mellon Speaker: Ed Harrington

Ed Harrington (MBA 2000), Chief Financial Officer at Genentech, presented at the Tepper School on Oct. 5. Sponsored by the Healthcare Club, Tepper professor and former dean Robert Dammon moderated this in-person talk.

Ed Harrington is Genentech’s chief financial officer. He assumed this role in January 2016. Ed leads the Genentech and Pharma North America Finance organizations as well as the Genentech Site Services function. He is a member of the Genentech Executive Committee and the Global Pharma Finance Leadership Team.

Ed joined Roche in 2001 as finance director, U.S. Consumer Health in Nutley, New Jersey. Following this role, he was finance director, US Pharma Alliances, General and Administrative, Tech Services, IT in New Jersey from 2003-2006. Ed moved to Switzerland in 2006 as global head of Pharma Strategic Alliances and R&D Portfolio Controlling through 2009. He then joined Roche Canada as vice president and chief financial officer from 2010-2012.

In 2013, Ed moved to Roche China where he was vice president, Finance. In this role, he was responsible for Finance, Procurement, and Business Development. Prior to joining Roche, Ed held both finance and accounting positions in companies including J. P. Morgan and Ernst & Young.

Ed received his bachelor’s degree in accounting from Robert Morris University and an MBA in finance and international business management from Carnegie Mellon University.